Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | PNP | P00491 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9079968 | 1.00 | HIF1A (0.60) | HIF1ASLC29A1ADORA3PNPLMNA | |
| SCHEMBL30208528 | 0.93 | HIF1A (0.56) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL21011332 | 0.89 | HIF1A (0.67) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL21011330 | 0.89 | HIF1A (0.67) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL30011905 | 0.89 | HIF1A (0.67) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL21545786 | 0.89 | HIF1A (0.64) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL7035979 | 0.86 | SLC29A1 (0.57) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL9446435 | 0.86 | SLC29A1 (0.57) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL7133533 | 0.86 | HIF1A (0.56) | HIF1ASLC29A1ADORA3 | |
| SCHEMBL9230450 | 0.86 | SLC29A1 (0.59) | HIF1ASLC29A1ADORA3TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2809737-B1 | WATER BASED PRIMER COMPOSITION FOR BONDING GLASS INTO A STRUCTURE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-06-06 | — | — | EP | claimed |
| EP-0355131-B1 | ACYL DEOXYRIBONUCLEOSIDE DERIVATIVES AND USES THEREOF | PRO NEURON INC (US) | 1996-09-04 | — | — | EP | claimed |
| WO-2022005101-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF FATTY LIVER DISEASE | 연세대학교 산학협력단 | 2022-01-06 | — | — | WO | disclosed |
| EP-0355131-B1 | ACYL DEOXYRIBONUCLEOSIDE DERIVATIVES AND USES THEREOF | PRO NEURON INC (US) | 1996-09-04 | — | — | EP | disclosed |
| EP-0550704-B1 | BIOTENSIDE ESTERS WITH VITAMIN D COMPOUNDS; THEIR PREPARATION AND TRANSFORMATION INTO SPONTANEOUSLY DISPERSIBLE CONCENTRATES, AND THEIR USE FOR TREATING TUMORS | MARIGEN SA (CH) | 1995-06-21 | — | — | EP | disclosed |